(Q38573442)

English

Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.

scientific article published on 10 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Brandy Wicklow

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Kristy Wittmeier

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Geert W T' Jong

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Jonathon McGavock

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Marni Robert

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Vernon W Dolinsky

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

10 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Biochemistry and Cell Biology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

93

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

522-530

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Resveratrol improves health and survival of mice on a high-calorie diet

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Resveratrol commonly displays hormesis: occurrence and biomedical significance

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Pilot study of resveratrol in older adults with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

High burden of kidney disease in youth-onset type 2 diabetes

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Earlier onset of complications in youth with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Calorie restriction and resveratrol in cardiovascular health and disease

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Experimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculature

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted.

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL.

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Acute and chronic complications of type 2 diabetes mellitus in children and adolescents

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Automatic quantitation of localized in vivo 1H spectra with LCModel.

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice.

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Cardiorespiratory fitness and physical activity in youth with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Metabolic consequences of hepatic steatosis in overweight and obese adolescents

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Hepatic steatosis and low cardiorespiratory fitness in youth with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2014-0136

21 January 2018

Identifiers

10.1139/BCB-2014-0136

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305052%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38573442&oldid=1767160166"